<?xml version="1.0"?>
<notificationOfRemoval>

    <schemaVersion>X0203</schemaVersion>

    <exchange>
        <cik>0001354457</cik>
        <entityName>Nasdaq Stock Market LLC</entityName>
    </exchange>

    <issuer>
        <cik>0001974640</cik>
        <entityName>Apogee Therapeutics, Inc.</entityName>
        <fileNumber>001-41740</fileNumber>
        <address>
            <street1>221 Crescent St</street1>
            <street2>Building 17, Suite 102b</street2>
            <city>Waltham</city>
            <stateOrCountryCode>MA</stateOrCountryCode>
            <stateOrCountry>MASSACHUSETTS</stateOrCountry>
            <zipCode>02453</zipCode>
        </address>
        <telephoneNumber>(650) 394-5230</telephoneNumber>
    </issuer>

    <descriptionClassSecurity>Common Stock</descriptionClassSecurity>

    <ruleProvision>17 CFR 240.12d2-2(a)(3)</ruleProvision>

    <signatureData>
        <signatureName>Tara Petta</signatureName>
        <signatureTitle>AVP</signatureTitle>
        <signatureDate>2026-09-03</signatureDate>
    </signatureData>
</notificationOfRemoval>